Latest Insider Transactions at Unitedhealth Group Inc (UNH)
This section provides a real-time view of insider transactions for Unitedhealth Group Inc (UNH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of UNITEDHEALTH GROUP INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of UNITEDHEALTH GROUP INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 16
2024
|
Brian R Thompson CEO, UnitedHealthcare |
BUY
Exercise of conversion of derivative security
|
Direct |
82,348
+21.78%
|
$19,681,172
$239.07 P/Share
|
|
Feb 14
2024
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
136
-1.51%
|
$70,176
$516.94 P/Share
|
|
Feb 14
2024
|
Dirk C Mc Mahon President & COO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
726
-1.15%
|
$374,616
$516.94 P/Share
|
|
Feb 14
2024
|
Brian R Thompson CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
307
-0.96%
|
$158,412
$516.94 P/Share
|
|
Feb 14
2024
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
786
-0.52%
|
$405,576
$516.94 P/Share
|
|
Feb 14
2024
|
Thomas E Roos Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
294
-0.9%
|
$151,704
$516.94 P/Share
|
|
Feb 14
2024
|
Andrew Witty CEO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
1,049
-1.36%
|
$541,284
$516.94 P/Share
|
|
Feb 13
2024
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
221
-2.39%
|
$114,036
$516.85 P/Share
|
|
Feb 13
2024
|
Dirk C Mc Mahon President & COO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
562
-0.88%
|
$289,992
$516.85 P/Share
|
|
Feb 13
2024
|
Brian R Thompson CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
340
-1.05%
|
$175,440
$516.85 P/Share
|
|
Feb 13
2024
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
924
-0.6%
|
$476,784
$516.85 P/Share
|
|
Feb 13
2024
|
Thomas E Roos Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
409
-1.23%
|
$211,044
$516.85 P/Share
|
|
Feb 13
2024
|
Andrew Witty CEO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
1,101
-1.4%
|
$568,116
$516.85 P/Share
|
|
Jan 02
2024
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
163
+2.15%
|
-
|
|
Jan 02
2024
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
174
+1.79%
|
-
|
|
Jan 02
2024
|
Charles D. Baker Director |
BUY
Grant, award, or other acquisition
|
Direct |
110
+50.0%
|
-
|
|
Jan 02
2024
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
174
+3.54%
|
-
|
|
Jan 02
2024
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
105
+0.27%
|
-
|
|
Jan 02
2024
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
174
+3.22%
|
-
|
|
Jan 02
2024
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
178
+1.39%
|
-
|
|
Jan 02
2024
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
265
+0.04%
|
-
|
|
Jan 02
2024
|
Gil Kristen Director |
BUY
Grant, award, or other acquisition
|
Direct |
163
+10.24%
|
-
|
|
Dec 13
2023
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
298
-0.19%
|
$163,602
$549.01 P/Share
|
|
Dec 13
2023
|
Dirk C Mc Mahon President & COO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
298
-0.47%
|
$163,602
$549.01 P/Share
|
|
Dec 12
2023
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
28
+0.3%
|
-
|
|
Dec 12
2023
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
63
+0.04%
|
-
|
|
Dec 12
2023
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
3
+0.08%
|
-
|
|
Dec 12
2023
|
Rupert M Bondy EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.23%
|
-
|
|
Dec 12
2023
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
21
+0.17%
|
-
|
|
Dec 12
2023
|
Erin Mc Sweeney EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.25%
|
-
|
|
Dec 12
2023
|
Gil Kristen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.34%
|
-
|
|
Dec 12
2023
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.33%
|
-
|
|
Dec 12
2023
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.05%
|
-
|
|
Dec 12
2023
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.0%
|
-
|
|
Dec 12
2023
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.35%
|
-
|
|
Dec 12
2023
|
Dirk C Mc Mahon President & COO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
63
+0.1%
|
-
|
|
Dec 12
2023
|
Brian R Thompson CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
38
+0.12%
|
-
|
|
Dec 12
2023
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
86
+0.11%
|
-
|
|
Dec 12
2023
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
122
+0.31%
|
-
|
|
Dec 05
2023
|
Stephen J Hemsley Director |
SELL
Open market or private sale
|
Direct |
66,081
-9.42%
|
$36,344,550
$550.39 P/Share
|
|
Dec 05
2023
|
Stephen J Hemsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66,081
+8.61%
|
$7,136,748
$108.97 P/Share
|
|
Nov 22
2023
|
Stephen J Hemsley Director |
SELL
Bona fide gift
|
Direct |
18,500
-2.83%
|
-
|
|
Nov 16
2023
|
Stephen J Hemsley Director |
SELL
Bona fide gift
|
Direct |
22,259
-3.29%
|
-
|
|
Nov 06
2023
|
Andrew Witty CEO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
372
-0.47%
|
$198,276
$533.46 P/Share
|
|
Oct 17
2023
|
Stephen J Hemsley Director |
SELL
Open market or private sale
|
Direct |
121,515
-18.89%
|
$65,618,100
$540.58 P/Share
|
|
Oct 17
2023
|
Stephen J Hemsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
121,515
+8.84%
|
$10,814,835
$89.61 P/Share
|
|
Oct 16
2023
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Open market or private sale
|
Direct |
4,498
-32.79%
|
$2,446,912
$544.28 P/Share
|
|
Oct 16
2023
|
Erin Mc Sweeney EVP & Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,498
+24.7%
|
$1,358,396
$302.2 P/Share
|
|
Oct 02
2023
|
Gil Kristen Director |
BUY
Grant, award, or other acquisition
|
Direct |
171
+13.5%
|
-
|
|
Oct 02
2023
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
277
+0.05%
|
-
|